BrightSpire Capital Inc (BRSP) concluded trading on Wednesday at a closing price of $5.12, with 0.46 million shares of worth about $2.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.24% during that period and on June 18, 2025 the price remained unchanged. Currently the company’s common shares owned by public are about 130.66M shares, out of which, 127.21M shares are available for trading.
Stock saw a price change of -4.12% in past 5 days and over the past one month there was a price change of -2.85%. Year-to-date (YTD), BRSP shares are showing a performance of -9.22% which decreased to -8.22% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.16 but also hit the highest price of $6.58 during that period. The average intraday trading volume for BrightSpire Capital Inc shares is 687.92K. The stock is currently trading -0.60% below its 20-day simple moving average (SMA20), while that difference is up 2.18% for SMA50 and it goes to -9.04% lower than SMA200.
BrightSpire Capital Inc (NYSE: BRSP) currently have 130.66M outstanding shares and institutions hold larger chunk of about 66.50% of that.
The stock has a current market capitalization of $667.97M and its 3Y-monthly beta is at 1.57. It has posted earnings per share of -$0.56 in the same period. It has Quick Ratio of 1.01 while making debt-to-equity ratio of 2.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BRSP, volatility over the week remained 0.93% while standing at 1.74% over the month.
Stock’s fiscal year EPS is expected to drop by -22.42% while it is estimated to increase by 8.64% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Alliance Global Partners on January 17, 2025 offering a Buy rating for the stock and assigned a target price of $7.25 to it. On May 03, 2024, Raymond James Downgrade their recommendations, while on March 04, 2024, BofA Securities Downgrade their ratings for the stock with a price target of $6.50. Stock get an Equal weight rating from Barclays on November 15, 2023.
